Bramshill Investments’s Pfizer PFE Stock Holding History

Bramshill Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$708K	Buy	29,388 +2,130	+8%	+$55.7K	0.05%	106
2026 Q1	$765K	Sell	27,258 -1,369	-5%	-$36.4K	0.07%	82
2025 Q4	$713K	Buy	+28,627	New	+$722K	0.04%	93
2024 Q1	–	Sell	-1,460	Closed	-$59.4K	–	190
2023 Q4	$59.4K	Hold	1,460	–	–	0.01%	152
2023 Q3	$59.4K	Hold	1,460	–	–	0.01%	114
2023 Q2	$59.4K	Hold	1,460	–	–	0.01%	131
2023 Q1	$59.4K	Sell	1,460 -64,487	-98%	-$2.79M	0.01%	133
2022 Q4	$3.38M	Sell	65,947 -420	-0.6%	-$20.1K	0.4%	28
2022 Q3	$2.9M	Buy	66,367 +6,626	+11%	+$322K	0.41%	36
2022 Q2	$3.13M	Buy	59,741 +6,550	+12%	+$334K	0.37%	31
2022 Q1	$2.75M	Buy	+53,191	New	+$2.76M	0.38%	39

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bramshill Investments's PFE Position: Q2 2026 in Review

Bramshill Investments increased its Pfizer (PFE) stake by 7.8% in Q2 2026, buying an estimated $55.7K and bringing the position to 29,388 shares worth $708K. The position accounts for 0.05% of the portfolio, ranked #106.

Bramshill Investments first reported a position in PFE in Q1 2022 and has held it in 11 quarters since. The position peaked at $3.38M in Q4 2022. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Bramshill Investments held 29,388 shares of Pfizer worth $708K as of Q2 2026.
Bramshill Investments bought 2,130 Pfizer shares in Q2 2026, an estimated $55.7K.
Pfizer made up 0.05% of Bramshill Investments's portfolio in Q2 2026, its #106 holding.
Bramshill Investments first reported a position in Pfizer in Q1 2022 and has held it in 11 quarters since.
Bramshill Investments's Pfizer position peaked at $3.38M in Q4 2022.
2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bramshill Investments's 13F filing for Q2 2026, filed 14 Aug 2026.